Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients

Zhytnik, L., Maasalu, K., Reimann, E., Prans, E., Kõks, S. and Märtson, A. (2017) Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. Human Genomics, 11 (1).

[img]
Preview
PDF - Published Version
Download (796kB) | Preview
Free to read: https://doi.org/10.1186/s40246-017-0115-5
*No subscription required

Abstract

Background
Osteogenesis imperfecta (OI) is a rare bone disorder. In 90% of cases, OI is caused by mutations in the COL1A1/2 genes, which code procollagen α1 and α2 chains. The main aim of the current research was to identify the mutational spectrum of COL1A1/2 genes in Estonian patients. The small population size of Estonia provides a unique chance to explore the collagen I mutational profile of 100% of OI families in the country.

Methods
We performed mutational analysis of peripheral blood gDNA of 30 unrelated Estonian OI patients using Sanger sequencing of COL1A1 and COL1A2 genes, including all intron-exon junctions and 5′UTR and 3′UTR regions, to identify causative OI mutations.

Results
We identified COL1A1/2 mutations in 86.67% of patients (26/30). 76.92% of discovered mutations were located in the COL1A1 (n = 20) and 23.08% in the COL1A2 (n = 6) gene. Half of the COL1A1/2 mutations appeared to be novel. The percentage of quantitative COL1A1/2 mutations was 69.23%. Glycine substitution with serine was the most prevalent among missense mutations. All qualitative mutations were situated in the chain domain of pro-α1/2 chains.

Conclusion
Our study shows that among the Estonian OI population, the range of collagen I mutations is quite high, which agrees with other described OI cohorts of Northern Europe. The Estonian OI cohort differs due to the high number of quantitative variants and simple missense variants, which are mostly Gly to Ser substitutions and do not extend the chain domain of COL1A1/2 products.

Item Type: Journal Article
Publisher: BioMed Central
Copyright: © 2017 The Author(s).
URI: http://researchrepository.murdoch.edu.au/id/eprint/51136
Item Control Page Item Control Page

Downloads

Downloads per month over past year